Table 2.
Mortality indicators.
Sr. number | Author, year of publication | Median follow-up period | Death, n (%) |
Mortality incidence density/100 PY | Mean survival time (95% CI) | Mortality at each period | ||
---|---|---|---|---|---|---|---|---|
First 3 months | First 6 months | First 12 months | ||||||
(1) | Hambisa MT et al., 2013 | 47 months | 30 (7.2%) | 1.89 | NR | NR | 17 (56.7%) | 21 (70%) |
| ||||||||
(2) | Tsehaineh B. et al., unpublished | 40 months | 144 (17.3%) | NR | 63.7 months (61.1–66.3) | 70 (48.6%) | 99 (68.8%) | NR |
| ||||||||
(3) | Setegn et al., 2015 | NR | 120 (5.9%) | 2.03 | 34.9 months (33.8–35.9) | NR | NR | 78 (65%) |
| ||||||||
(4) | Biadgilign S. et al., 2012 | NR | 86 (5.6%) | 2.03 | NR | NR | NR | 63 (73.3%) |
| ||||||||
(5) | Kassa A. et al., 2012 | NR | 291 (6.9%) | 2.8 | NR | NR | 166 (57%) | NR |
| ||||||||
(6) | Seyoum D. et al., 2017 | NR | 66 (14.5%) | 5.3 | 34 months (22.8–42.0) | NR | NR | 40 (60.6%) |
| ||||||||
(7) | Damtew B. et al., 2015 | 60 months | 87 (11.1) | 5.15 | 20.7 months | 49 (56.3%) | NR | NR |
| ||||||||
(8) | Alemu AW and Sebastian MS, 2010 | 28 (10.3%) | 7 | NR | NR | NR | NR | |
| ||||||||
(9) | Ayalew et al., 2014 | NR | 92 (14.1%) | NR | 41.8 months (40.61–43.00) | NR | NR | NR |
| ||||||||
(10) | Ahunie MA and Ebrahim EA | NR | 35 (5.0%) | 1.5 | NR | NR | NR | NR |
| ||||||||
(11) | Abebe N et al., 2014 | NR | 261 (40.8%) | 10.74 | NR | NR | NR | NR |
| ||||||||
(12) | Tadesse K et al., 2014 | 32 months | 46 (8.9%) | 3.2 | NR | NR | NR | 27 (59%) |
| ||||||||
(13) | Bedru A. and worku A, unpublished | 34 months | 360 (33.6%) | NR | NR | 200 (55.6%) | NR | NR |
| ||||||||
(14) | Mengesha S et al., 2014 | 34 months | 37 (9%) | 3.8 | 39 months | 22 (59.5%) | NR | NR |
| ||||||||
(15) | Moshago T et al., 2012 | NR | 159 (5.9%) | 0.2 | 89 months | NR | NR | NR |
| ||||||||
(16) | Sapa et al., 2016 | 25 months | 128 (9.2%) | 3.5 | NR | 33 (26%) | NR | 66 (52%) |
| ||||||||
(17) | Kebebew K and wencheko E, 2012 | 38.5 months | 86 (11.7%) | NR | NR | 28 (32.6%) | 43 (50%) | 86 (100%) |
NR: not reported.